Uniphar PLC
LSE:UPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Uniphar PLC
LSE:UPR
|
IE |
|
K
|
Key ASIC Bhd
KLSE:KEYASIC
|
MY |
|
T
|
Technogym SpA
F:TN2
|
IT |
|
S
|
Summarecon Agung Tbk PT
SWB:RZU
|
ID |
Intrinsic Value
Is UPR undervalued or overvalued?
See the intrinsic value estimate for Uniphar PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
UPR looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with UPR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Uniphar Does
Uniphar PLC is a healthcare services company that helps drug makers, pharmacies, hospitals, and doctors get medicines and related products where they need to go. It sits in the middle of the healthcare supply chain, handling buying, storage, distribution, and commercial support for pharmaceutical products, medical devices, and other healthcare goods. The company also works with drug manufacturers to help launch, market, and manage products in different countries.
- Headquarters
- Ireland IE
- Employees
- 3 500
- IPO date
- Jul 17, 2019
Earnings Waterfall
Uniphar PLC
The intrinsic value for Uniphar PLC (UPR) under the Base Case is hidden GBX.
Compared with the current market price of 342 GBX, the stock appears hidden.